Lindy Durrant is to become sole chief executive of Scancell Holdings Plc, a company which she founded in 1997 on the basis of research she led at the University of Nottingham, UK. Professor Durrant is currently a board member and chief scientific officer at the company, and also served as co-CEO. Her fellow CEO, Cliff Holloway is stepping down. As well as her work at Scancell, Prof Durrant has spent nearly 20 years as professor of cancer immunotherapy at the University of Nottingham.
Scancell announced the appointment on 28 July 2021.
Copyright 2021 Evernow Publishing Ltd